Use of high-normal levels of haemoglobin A1C and fasting plasma glucose for diabetes screening and for prediction: A meta-analysis

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 8, 2013, Pages 680-692

  Kodama, Satoru ^a,b   Horikawa, Chika ^b   Fujihara, Kazuya ^c   Hirasawa, Reiko ^b   Yachi, Yoko ^b   Yoshizawa, Sakiko ^b   Tanaka, Shiro ^d   Sone, Yasuko ^e   Shimano, Hitoshi ^c   Iida, Kaoruko Tada ^e   Saito, Kazumi ^f   Sone, Hirohito ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e OCHANOMIZU UNIVERSITY   (Japan)

^f IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Blood glucose; Diagnosis; Haemoglobin A, glycosylated; Hyperglycemia; Mass screening; Meta analysis

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ABNORMAL LABORATORY RESULT; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FASTING PLASMA GLUCOSE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MEDICAL LITERATURE; META ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING; SYSTEMATIC REVIEW;

BLOOD GLUCOSE; DIAGNOSIS; HAEMOGLOBIN A, GLYCOSYLATED; HYPERGLYCEMIA; MASS SCREENING; META-ANALYSIS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS;

EID: 84887677826     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2445     Document Type: Article

References (55)

1. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002; 137(4): 263-272.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(Suppl 1): S62-69.
3. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 2009; 32(Suppl 2): S194-198.
4. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007; 24(4): 333-343.
5. Jesudason DR, Dunstan K, Leong D, Wittert GA. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening. Diabetes Care 2003; 26(2): 485-490.
6. Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 2011; 124(5): 395-401.
7. Herdzik E, Safranow K, Ciechanowski K. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Acta Diabetol 2002; 39(1): 15-22.
8. Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004; 50(1): 166-174.
9. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006; 163(7): 670-675.
10. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6: 9.
11. Schunemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336(7653): 1106-1110.
12. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Thompson JR. Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol 2007; 7: 3.
13. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001; 20(19): 2865-2884.
14. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007; 8(2): 239-251.
15. Jaeschke R, Guyatt GH, Sackett DL. Users' Guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA 1994; 271(9): 703-707.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-560.
17. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58(9): 882-893.
18. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148(3): 839-843.
19. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012; 13(3): 275-286.
20. Harbord RM. Metandi: Stata module for meta-analysis of diagnostic accuracy. Statistical Software Components S456932. Boston College Department of Economics, 2008. Accessed at http://EconPapers.repec.org/RePEc:boc:bocode:s456932.
21. Dwamena B. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Statistical Software Components S456880. Boston College Department of Economics, 2007. Accessed at http://econpapers.repec.org/software/bocbocode/s456880.htm.
22. Hu Y, Liu W, Chen Y, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010; 47(3): 231-236.
23. Kim KS, Kim SK, Lee YK, Park SW, Cho YW. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Diabet Med 2008; 25(8): 997-1000.
24. Law LS, Tso AW, Tam S, Wat NM, Cheung BM, Lam KS. Haemoglobin A1c is superior to fasting glucose in predicting the incidence of diabetes over 8years among Chinese. Diabetes Res Clin Pract 2011; 91(2): e53-56.
25. Li HY, Lin MS, Shih SR, et al. The performance of risk scores and hemoglobin A1c to find undiagnosed diabetes with isolated postload hyperglycemia. Endocr J 2011; 58(6): 441-448.
26. Nakagami T, Tajima N, Oizumi T, et al. Hemoglobin A1c in predicting progression to diabetes. Diabetes Res Clin Pract 2010; 87(1): 126-131.
27. Tahrani AA, Geen J, Hanna FW, et al. Predicting dysglycaemia in patients under investigation for acute coronary syndrome. QJM 2011; 104(3): 231-236.
28. Zhou X, Pang Z, Gao W, et al. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care 2010; 33(3): 545-550.
29. Nakagami T, Tominaga M, Nishimura R, et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007; 76(2): 251-256.
30. Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 2003; 26(2): 290-296.
31. Glumer C, Jorgensen T, Borch-Johnsen K. Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8). Diabet Med 2004; 21(8): 874-880.
32. Heianza Y, Hara S, Arase Y, et al. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011; 378(9786): 147-155.
33. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000; 23(12): 1770-1773.
34. Ko GT, Chan JC, Yeung VT, et al. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998; 21(8): 1221-1225.
35. Norberg M, Eriksson JW, Lindahl B, et al. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med 2006; 260(3): 263-271.
36. Salmasi AM, Dancy M. The glucose tolerance test, but not HbA(1c), remains the gold standard in identifying unrecognized diabetes mellitus and impaired glucose tolerance in hypertensive subjects. Angiology 2005; 56(5): 571-579.
37. Tavintharan S, Chew LS, Heng DM. A rational alternative for the diagnosis of diabetes mellitus in high risk individuals. Ann Acad Med Singapore 2000; 29(2): 213-218.
38. Badings EA, Dyal L, Schoterman L, et al. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. J Diabetes 2011; 3(3): 232-237.
39. Cederberg H, Saukkonen T, Laakso M, et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010; 33(9): 2077-2083.
40. Inoue K, Matsumoto M, Akimoto K. Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. Diabet Med 2008; 25(10): 1157-1163.
41. Inoue K, Matsumoto M, Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 2007; 77(3): 451-458.
42. Papoz L, Favier F, Sanchez A, et al. Is HbA1c appropriate for the screening of diabetes in general pratice? Diabetes Metab 2002; 28(1): 72-77.
43. Sato KK, Hayashi T, Harita N, et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009; 32(4): 644-646.
44. Soulimane S, Simon D, Shaw J, et al. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Res Clin Pract 2011. doi:10.1016/j.diabres.2011.06.003.
45. Takahashi M, Kaji K, Togashi A, Ogino Y, Shibosawa T, Kawazu S. Usefulness of paired estimation of fasting plasma glucose and HbA1c: a long-term follow-up study of screened nondiabetic subjects. J Japan Diab Soc 2001; 44(9): 745-750.
46. Wang W, Lee ET, Howard BV, Fabsitz RR, Devereux RB, Welty TK. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study. Diabetes Care 2011; 34(2): 363-368.
47. Zhang J, Yang Q, Zhang J-A, et al. The value of HbA1c for diagnosing type 2 diabetes in high-risk population. Journal of Xi'an Jiaotong University (Medical Sciences) 2010; 31(4): 512-514.
48. Mukai N, Doi Y, Ninomiya T, et al. Cut-off values of fasting and post-load plasma glucose and HbA(1c) for predicting type 2 diabetes in community-dwelling Japanese subjects: the Hisayama study. Diabet Med 2012; 29(1): 99-106.
49. Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011; 34(4): 944-949.
50. Schottker B, Raum E, Rothenbacher D, Muller H, Brenner H. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol 2011; 26(10): 779-787.
51. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 2011; 154(5): 303-309.
52. Resnick HE, Shorr RI, Kuller L, Franse L, Harris TB. Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study. J Clin Epidemiol 2001; 54(9): 869-876.
53. Williams JW, Zimmet PZ, Shaw JE, et al. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in mauritius. Does sex matter? Diabet Med 2003; 20(11): 915-920.
54. Pani LN, Korenda L, Meigs JB, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008; 31(10): 1991-1996.
55. Miyazaki M, Kubo M, Kiyohara Y, et al. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama study. Diabetologia 2004; 47(8): 1411-1415.